Skip to main content
IMTX logo

Immatics N.V.

IMTXNASDAQHealthcareBiotechnology

$7.15Today:- (-)1Y −25.93%

As of Oct 26, 2026 close

Market cap
$977.26M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.65$12.41
Volume (live)
-
Avg. volume (3M)
959.26K

Immatics (IMTX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Immatics used EUR 169.66M of cash in operating activities and spent EUR 6.30M on capital expenditures. That left free cash flow of −EUR 175.95M.

Immatics Cash Flow Statement Analysis

Values in millions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Immatics N.V. (IMTX) - Annual data in millions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-188.6921.35-94.6537.51-93.34-211.28-32.49-32.36
Depreciation & Amortization11.9112.237.236.975.264.423.862.18
Deferred Income Tax0.006.13-2.354.5211.15-3.960.620.49
Stock Based Compensation0.0017.6420.7122.5726.4018.630.851.48
Change in Working Capital-42.23-150.7884.5937.26-31.70-25.2896.8849.17
Change in Accounts Receivable-0.23-1.76-2.98-0.430.57-0.29-0.56-0.18
Change in Inventory0.000.00-84.240.000.000.000.000.00
Change in Accounts Payable-36.13-149.7484.2445.56-31.78-23.3998.9443.73
Change in Other Working Capital-5.8715.45-13.01-7.870.43-1.60-1.505.61
Other Operating Activities49.36-60.08-13.01-8.700.43-19.971.24-0.27
Net Cash from Operating Activities-169.66-158.0318.23100.13-84.75-80.7070.9720.68
Investing Activities
Capital Expenditures-6.30-16.27-30.96-6.22-5.66-7.42-2.23-0.51
Acquisitions0.000.000.00-199.910.550.100.090.10
Purchases of Investments-324.92-450.35-415.33-216.32-11.30-8.43-77.81-13.10
Sales/Maturities of Investments528.16314.44414.7412.7024.45-0.1074.890.00
Other Investing Activities0.00-0.21-0.01199.96-0.55-0.100.010.09
Net Cash from Investing Activities196.70-152.39-31.39-209.797.49-15.95-5.06-13.51
Financing Activities
Debt Repayment0.00-2.01-3.85-2.84-2.71-2.10-1.860.00
Common Stock Issued96.35343.0190.40134.480.09217.920.0023.65
Other Financing Activities-2.84-21.31-2.04-7.930.00-7.940.000.00
Net Cash from Financing Activities93.51319.6884.52123.71-2.61207.88-1.8623.65
Summary
Effect of Forex Changes on Cash16.569.01-1.401.485.33-2.15-0.060.13
Net Change in Cash137.1218.2871.3615.53-79.87104.1863.9930.95
Cash at Beginning of Period208.65218.47148.52132.99207.53103.3539.378.42
Cash at End of Period345.77236.75218.47148.52132.99207.53103.3539.37
Free Cash Flow-175.95-174.30-12.7393.92-90.40-88.1268.7320.18
Supplemental Disclosures
Interest Paid0.950.890.290.700.570.29--
Income Taxes Paid4.4313.102.960.22----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immatics Cash Flow

What is Immatics's free cash flow?

Immatics had negative free cash flow of EUR 175.95M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −EUR 169.66M minus EUR 6.30M of capital expenditures.

How much does Immatics spend on capital expenditures?

Immatics spent EUR 6.30M on capital expenditures in fiscal 2025, compared with EUR 16.27M a year earlier.

Does Immatics pay dividends or buy back shares?

Immatics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition